1 |
Jiang CG, Wang W, Zhou Q, et al. Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis[J]. BMC Pulm Med, 2020, 20(1): 178.
|
2 |
李王平,李春梅,潘 蕾,等. 两种不同诊治方法对结核性胸膜炎临床路径住院日变异的影响因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(2): 134-136.
|
3 |
梁亚充,王国卫,马 丽,等. 胸水IL-27、ADA联合GeneXpert MTB/RIF对结核性胸膜炎的诊断价值[J]. 标记免疫分析与临床,2022, 29(3): 443-447.
|
4 |
Valdes L, Jose ES, Ferreiro L, et al. Interleukin 27 could be useful in the diagnosis of tuberculous pleural effusions.[J]. Respir Care, 2014, 59(3): 399-405.
|
5 |
Antonangelo L, Faria CS, Sales RK. Tuberculous pleural effusion: diagnosis & management[J]. Expert Rev Respir Med, 2019, 13(8): 747-759.
|
6 |
Li D, Shen Y, Fu X, et al. Combined detections of interleukin-33 and adenosine deaminase for diagnosis of tuberculous pleural effusion[J]. Int J Clin Exp Pathol, 2015, 8(1): 888-893.
|
7 |
高景利,崔俊伟,石卓林,等. 胸腔积液中微RNA-29a和腺苷脱氨酶联合检测对结核性胸膜炎的临床诊断效能[J]. 新乡医学院学报,2021, 38(8): 746-750.
|
8 |
Zeng N, Wan C, Qin J, et al. Diagnostic value of interleukins for tuberculous pleural effusion: a systematic review and meta-analysis[J]. BMC Pulm Med, 2017, 17(1): 180.
|
9 |
Ye ZJ, Zhou Q, Yuan ML, et al. Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy.[J]. Am J Respir Crit Care Med, 2012, 185(6): 660-669.
|
10 |
高孟秋. 《WS 288-2017肺结核诊断》新标准中关于临床诊断患者判定的解析[J]. 中国防痨杂志,2018, 40(3): 243-246.
|
11 |
中国恶性胸腔积液诊断与治疗专家共识组. 恶性胸腔积液诊断与治疗专家共识[J]. 中华内科杂志,2014, 53(3): 252-256.
|
12 |
彭 泽,黄 健,任 莉,等. 胸腔积液IGRA、ADA、IL-27诊断结核性胸膜炎患者的价值[J]. 热带医学杂志,2021, 21(9): 1175-1179.
|
13 |
吴艳飞,张 令. 胸水中LPS、IL-35、RORα在结核性胸腔积液中的表达变化及临床意义[J]. 国际呼吸杂志,2021, 41(3): 172-177.
|
14 |
石 慧,崔丽英. 结核感染T细胞斑点试验诊断结核性胸膜炎的应用价值[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 195-199.
|
15 |
Zhang M, Xiong D, Li H, et al. Diagnostic value of T-Spot TB combined with INF-γ and IL-27 in tuberculous pleurisy[J]. Exp Ther Med, 2018, 15(2): 1871-1874.
|
16 |
李翔云,李 峥,张泽明,等. 腺苷脱氨酶及IL-22对结核性胸膜炎诊断价值的探究[J]. 国际呼吸杂志,2020, 40(8): 604-607.
|
17 |
He J, Zh R, Sh Y, et al. Diagnostic accuracy of interleukin-22 and adenosine deaminase for tuberculous pleural effusions[J]. Curr Res Transl Med, 2018, 66(4): 103-106.
|
18 |
李 芳,张 坚,郝雪琦,等. 胸腔积液中IL-27和IFN-γ检测对结核性胸膜炎的诊断价值[J]. 吉林大学学报(医学版), 2019, 45(2): 353-358.
|
19 |
Zhang M, Niu YR, Liu JY, et al. Interleukin-26 upregulates interleukin-22 production by human CD4+ T cells in tuberculous pleurisy[J]. J Mol Med (Berl), 2019, 97(5): 619-631.
|
20 |
席素雅,乔庆哲,刘 薇,等. 白介素-27联合腺苷脱氢酶在结核性胸膜炎中的诊断价值[J]. 中国医刊,2022, 57(4): 382-385.
|
21 |
程 亮,陈华昕,赵新国,等. IL-27在结核性胸腔积液中的表达水平及临床意义[J]. 国际呼吸杂志,2019, 39(23): 1795-1799.
|
22 |
唐添祥,龙明伟,李俊华,等. 结核性胸腔积液患者胸水中白细胞介素-27、γ-干扰素、腺苷脱氨酶水平及临床意义[J]. 实用医院临床杂志,2019, 16(6): 141-144.
|
23 |
彭 丹,陈国强,童 凯,等. 血清ADA、IL-27、TB-Ab联合检测诊断血性结核性胸腔积液的价值研究[J]. 中国现代医学杂志,2020, 30(22): 91-94.
|
24 |
闫 慧,杜园园,李 鹏,等. 多项指标联合检测对结核性胸膜炎的诊断价值研究[J]. 中国卫生检验杂志,2021, 31(16): 1935-1939.
|
25 |
Paulo A, Juliana B, Carlos P, et al. Interleukin-6 and -27 as potential novel biomarkers for human pleural tuberculosis regardless of the immunological status[J]. Microbes Infect, 2023: 105238.
|